Video Experimental Relacionado
Updated: Jul 20, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Evaluación de un nuevo agente antidiurético, el acetato de desmopresina (DDAVP)
JAMA
|October 20, 1978
Resumen
El acetato de desmopresina, un análogo sintético de la vasopresina, es un tratamiento intranasal de acción prolongada y bien tolerado. Se considera una opción privilegiada para el manejo eficaz de la diabetes insipidus central.
Área de la Ciencia:
- Endocrinología Endocrinología.
- Farmacología Farmacología.
Sus antecedentes:
- La diabetes central insípida es una condición caracterizada por una producción insuficiente de la hormona antidiurética.
- Una gestión eficaz es crucial para prevenir la deshidratación y los desequilibrios electrolitos.
Objetivo del estudio:
- Evaluar el acetato de desmopresina como tratamiento para la diabetes insipida central.
- Para resaltar su eficacia y tolerabilidad a través de la administración intranasal.
Principales métodos:
- La administración de acetato de desmopresina a través de la vía intranasal.
- Evaluación de los efectos de acción prolongada y la tolerabilidad del paciente.
Principales resultados:
- El acetato de desmopresina demostró propiedades de acción prolongada.
- El tratamiento fue bien tolerado por los pacientes.
Conclusiones:
- El acetato de desmopresina es una opción terapéutica intranasal adecuada y efectiva.
- Es un agente potencial de elección para el tratamiento de la diabetes insipida central.
Videos de Conceptos Relacionados
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).